Table 2 Planning Target Volume (PTV) and Organ-At-Risk dose-volume constraints for plan optimization and patients violating the required constraints when the Auto Plan best optimization objective list was applied
From: Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment
Structure | Parameter | Required Objective | Patient violating the requirements | ||
|---|---|---|---|---|---|
AP-BF Training | AP-BF Validation | AP-ARC Validation | |||
PTV | |||||
|  | Dmean (Gy) | 30 | – | – | – |
|  | V95% (%) | 95 | – | – | – |
| Â | V107% (%) | 1 | 3,4 | 6,7,8 | 6,7 |
Breast | |||||
|  | V4Gy (%) | 50 | – | – | – |
|  | V10Gy (%) | 33 | – | – | – |
Lung-PTV | |||||
|  | V5Gy (%) | 50 | – | – | – |
|  | V10Gy (%) | 33 | – | – | – |
Thyroid-PTV | |||||
|  | Dmean (Gy) | 20 | 3 | – | – |
|  | V18Gy (%) | 50 | 3 | – | – |
|  | V25Gy (%) | 33 | – | – | – |
Heart-PTV | |||||
| Â | Dmean (Gy) | 3 | 2 | 6,8 | 6,8 |
|  | V7.7Gy(%) | 50 | – | – | – |
|  | V15Gy(%) | 33 | – | – | – |
Spinal Cord | |||||
|  | Dmax (Gy) | 30 | – | – | – |
Esophagus-PTV | |||||
|  | Dmax (Gy) | 32 | – | – | – |